Literature DB >> 8604334

RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity.

A Geiger1, P Burgstaller, H von der Eltz, A Roeder, M Famulok.   

Abstract

A completely randomized RNA pool as well as a degenerate pool comprised of an RNA sequence which binds citrulline with a dissociation constant of 0 muM were used to select for tight binding arginine specific RNA aptamers. A modified in vitro selection scheme, based on affinity chromatography was applied to allow the enrichment of high affinity solution binders. The selection scheme included a negative selection with the non-cognate ligand citrulline, and a heat denaturation step prior to affinity elution with an excess of the cognate ligand arginine. After 20 cycles the majority of the pools bound specifically to the arginine matrix even after denaturation/renaturation in the presence of 20 mM of a non-cognate amino acid. When denatured and eluted in the presence of 20 mM arginine, the selected RNAs quantitatively washed off the column. These RNA aptamers were cloned and sequenced. Equilibrium dialysis performed with the most abundant clone among the selected sequence revealed Kd values of 330 nM for the RNA/arginine affinity, which is nearly a 200-fold improvement over the tightest binding arginine binding RNAs known to date. Arginine recognition by this RNA is highly enantioselectice: L- arginine is bound 12 000-fold better than D-arginine. Chemical modification analysis revealed that the secondary structure of the aptamer might contain a pseudoknot motif. Our tight binding arginine aptamers join a number of natural and in vitro selected RNAs which recognize arginine. The RNAs described here compare in their binding affinity with the tightest binding RNA aptamers for low molecular weight molecules isolated in other in vitro selection experiments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604334      PMCID: PMC145747          DOI: 10.1093/nar/24.6.1029

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  70 in total

1.  In vitro selection of RNA aptamers that bind special elongation factor SelB, a protein with multiple RNA-binding sites, reveals one major interaction domain at the carboxyl terminus.

Authors:  S J Klug; A Hüttenhofer; M Famulok
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

2.  Guilt by association: the arginine case revisited.

Authors:  R D Knight; L F Landweber
Journal:  RNA       Date:  2000-04       Impact factor: 4.942

3.  The scene of a frozen accident.

Authors:  A D Ellington; M Khrapov; C A Shaw
Journal:  RNA       Date:  2000-04       Impact factor: 4.942

4.  RNA-ligand chemistry: a testable source for the genetic code.

Authors:  M Yarus
Journal:  RNA       Date:  2000-04       Impact factor: 4.942

5.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

6.  Selection of the simplest RNA that binds isoleucine.

Authors:  Catherine Lozupone; Shankar Changayil; Irene Majerfeld; Michael Yarus
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

7.  Isolation of high-affinity GTP aptamers from partially structured RNA libraries.

Authors:  Jonathan H Davis; Jack W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-16       Impact factor: 11.205

8.  Selection and evolution of NTP-specific aptamers.

Authors:  Laure Weill; Dominique Louis; Bruno Sargueil
Journal:  Nucleic Acids Res       Date:  2004-09-27       Impact factor: 16.971

9.  Isoalloxazine derivatives promote photocleavage of natural RNAs at G.U base pairs embedded within helices.

Authors:  P Burgstaller; T Hermann; C Huber; E Westhof; M Famulok
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

Review 10.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.